Abstract
Aims:
The aim of the study was to evaluate the difference in sodium, potassium, total protein in whole saliva in diabetic smokers, diabetic nonsmokers and healthy controls.
Materials and Methods:
Nonstimulated saliva samples were collected from a group of diabetic smokers, diabetic nonsmokers, and controls. Supernatant after centrifugation was used to determine the levels of sodium, potassium, and total protein by using semiautomatic analyzer.
Results:
There exists a statistical difference in the levels of potassium and total protein between diabetic smokers, nondiabetic smokers, and controls. Difference in the levels of sodium is only significant with nondiabetic smokers and controls.
Conclusion:
Diabetes mellitus is known to alter the composition of saliva. The purpose of this study was to estimate and compare the levels of salivary potassium, sodium, and total protein in smoker diabetic patients and nondiabetic smokers and controls, and to explore potential of salivary electrolytes [Na+, K+] and total proteins as markers. The estimated values of salivary constituents add to the data already recorded in Indian population. However, further studies using large samples are required to evaluate the findings in our study.
Keywords: Diabetes, potassium, saliva, smoking, total protein
INTRODUCTION
Human saliva contains a large number of proteins and peptides that are easily accessible and may serve as a potential source of biomarkers to monitor changes that occur under pathological conditions. The value of saliva as a biological fluid for the detection of diagnostic and prognostic biomarkers has become increasingly well established. Collection of human saliva is a simple, noninvasive, and cost-effective approach for screening large populations. It is easy to handle and may be repeated without inflicting much discomfort to the subjects.[1]
Diabetes mellitus is a major global health problem and it has an increasing prevalence due to several factors, such as the population growth, aging, urbanization, and increasing prevalence of obesity or lack of physical exercise. The number of people diagnosed with diabetes is increasing at an alarming rate. It is estimated that by the year 2030, 366 million people worldwide will have the disease.[2]
Worldwide, tobacco-related diseases cause about 5 million premature deaths per year. Most of these deaths occur in smokers. A widely used approach for measuring exposure is determination of tobacco-derived biomarkers in biologic fluids.[3]
The oral cavity is the first organ in the human body to be exposed to the cigarette smoke. The tobacco smoke alters normal homeostasis of the oral cavity, including the saliva's antioxidant and other protective systems. The mucosal changes in smokers may also arise from the drying effects of the mucosa, high intraoral temperatures, intraoral pH changes, local alteration of membrane barriers and immune responses, or altered resistance to bacteria, fungal, and viral infections. Smoking-related cell damage may leave molecular footprints in the saliva, offering the potential for noninvasive early diagnosis of tobacco-related oral diseases.[1]
Saliva, and not blood, was chosen as the sample used in the study, as many reports have suggested that saliva can be an alternative to blood.[4] Saliva contains a large number of proteins that have metabolic, immune response, transporting, and several other cellular functions. Its collection is noninvasive compared to the collection of other body fluids, and hence has a great potential for use in the diagnosis of systemic and localized diseases.[5,6]
There is very limited literature about salivary changes in diabetic smokers. Hence, we have made an attempt to analyze the levels of sodium, potassium, and total protein in diabetic smokers and nonsmokers in comparison with healthy controls.
MATERIALS AND METHODS
Subjects of either sex aged 30 years and above attending the Department of Oral Pathology and Microbiology, Bapuji Dental College and Hospital, Davangere was considered for inclusion in the study. This study was categorized into three different groups. Group I comprised of 25 known diabetic, nonsmoking patients, Group II comprised of 25 known diabetic smoking patients, and Group III comprised of 25 nondiabetic and nonsmoking controls.
The complete history was taken on a proforma devised for the study. The details of their habits, especially of smoking were specifically sought. A thorough general and oral examination was carried out and blood samples were collected for random blood sugar. Nonstimulated saliva samples were collected[7] and centrifuged for 30 min at 3000 rpm to obtain a clear supernatant fluid. The clear supernatant saliva was analyzed for sodium, potassium, and total protein using a semiautoanalyzer.[8,9,10]
Correlation between sialochemistry of Na+, K+, and the total protein levels and glycemic status in diabetics was determined. Salivary Na+, K+, and total protein levels between the groups were compared for statistical significance. Descriptive data that included mean, standard deviation, and percentages was calculated for each group. Multiple group comparisons were made by one-way ANOVA followed by unpaired t-test for pairwise comparisons. Categorical data were analyzed by Fisher's Exact Test. For all the tests, a P value of 0.05 or less was considered for statistical significance.
RESULTS
Total of 75 subjects were analyzed, out of which 25 were diabetic without smokers, 25 were diabetic smokers and 25 were healthy controls.
Group I comprised of 25 cases out of which 14 were males and 11 were females, age range varied from 32-86 years, mean and standard deviation of 51.3 ± 12.2. Group II comprised of 25 subjects were only males, age range varied from 30-76 years, mean and standard deviation of 50.2 ± 11.4. Group III is a control group with 13 males and 12 female subjects. The age range varied from 33-86 years, mean and standard deviation of 50.0 ± 13.1. The mean age in all groups was found to be statistically nonsignificant [Table 1].
Table 1.
Age and sex distribution between control and diabetics.

In Group I diabetic nonsmokers, the random blood sugar levels ranged from 143-428 mg% with mean and standard deviation of 278.9 ± 91.6 mg%. Salivary sodium levels ranged from 23.9-271.9 mmol/L with mean and standard deviation of 118.7 ± 80.8 mmol/L. Salivary potassium ranged from 7.2-24.5 mmol/L, mean and standard deviation of 13.6 ± 4.8 mmol/L. Similarly, Salivary total protein ranged from 0.74-1.39 with mean and standard deviation of 1.00 ± 0.19 mmol/L. In Group II diabetic smokers, the random blood sugar levels ranged from 149-522 mg% with mean and standard deviation of 296.7 ± 91.1mg%. Salivary sodium levels ranged from 27.0-217.3 mmol/L with mean and standard deviation of 92.1 ± 47.8 mmol/L. Salivary potassium levels ranged from 11.4-27.4 mmol/L with mean and standard deviation of 20.5 ± 5.7 mmol/L. Similarly, salivary total protein ranged from 0.91-1.92 mmol/L with the mean and standard deviation of 1.37 ± 0.35 mmol/L. In controls, the random blood sugar levels ranged from 65-116 mg% with the mean and standard deviation of 94.4 ± 13.3 mg%. Salivary sodium ranged from 11.5-217.3 mmol/L with mean and standard deviation of 80.0 ± 51.1 mmol/L. The salivary potassium range is from 2.6-18.3 mmol/L with mean and standard deviation of 8.9 ± 4.2 mmol/L and salivary total protein ranged from 0.01-0.94 mmol/L with mean and standard deviation of 0.47 ± 0.28 mmol/L [Table 2].
Table 2.
Groupwise Comparisons of Serum Glucose and Saliva Components.

On statistical analysis by unpaired “t” test, on comparison of salivary sodium [Graph 1] between Groups I and III, [“P” <0.05 with t = 2.02] statistical significance values were obtained. But there was no significance between Groups II and III, as well as Groups I and II. The value for the salivary potassium [Graph 2] showed high significance on comparison of Group I and Group III, Group II and Group III, and Group I and II. Total protein [Graph 3] also showed high significance between the groups, that is, on comparison of Group I and III, Group II and III as well as Group I and II.
Graph 1.

Groupwise Comparison of Salivary sodium
Graph 2.

Groupwise comparison of salivary potassium
Graph 3.

Groupwise comparison of salivary total protein
The statistical analysis by ANOVA factor showed a “P” value of <0.001 that was highly significant with “F” value of 55.8 for random blood sugar levels. For Salivary sodium, no significant difference of P = 0.08 with F = 2.57 was noted, but salivary potassium showed high significance P ≤ 0001 with F = 35.0. Similarly total protein showed high significance P ≤ 0.001 and F = 64.7.
DISCUSSION
Diabetes is known to influence the salivary composition and function.[11] The use of saliva rather than blood for diagnosis has recently been promoted.[12,13,14] Obtaining saliva is advantageous for patients, especially children and diabetic subjects, since the procedure is noninvasive, stress-free, and allows multiple samplings. The importance of optimal functioning of salivary glands in oral health is well known. Diabetes mellitus is one such disease affecting the salivary gland functioning[15] and thus altering the salivary constituents.
Sharon et al.,[16] Ben-Aryeh et al., and Yavuzyilmaz et al. analyzed whole saliva, and found significantly higher potassium levels in diabetic groups compared to the nondiabetic group.[17,18,19] Sharon et al. citing studies in animals have hypothesized that in diabetes mellitus an autonomic neuropathy exists that causes sympathetic–parasympathetic imbalance.[16] This imbalance may perhaps exert a continuous stimulation on the salivary glands, bringing about increased potassium secretion into the saliva. Mander et al. and Streckfus et al. analyzed individual gland saliva and they found no significant difference controls and diabetics.[20,21]
Marder et al. attempted to explain the higher concentration of potassium in whole saliva of diabetics by different factors such as peripheral vascular damage that had much higher potassium levels in diabetics than controls and elevated conductibility of the acinic cell membrane to potassium.[9] The findings of this study that whole saliva potassium levels are significantly higher in diabetic patients when compared to the control group. This result is in accordance with a previous study of Sharon et al.[16]
Laine et al. reported that smoking was associated with higher concentration of salivary potassium, sodium, and total protein. But this finding is entirely opposite of Khan et al. reported that potassium decreases with increase in the salivary flow rate of chronic tobacco users.[22] Our study showed significant increase in salivary potassium among diabetic smokers but the salivary sodium levels was not significant.
Total salivary protein levels in diabetic nonsmokers and diabetic smokers are increased on comparison with controls and our study is in general agreement with the findings of Yavuzyilmaz et al.,[19] Tenovero et al.,[23] Harrison et al.,[24] Pal et al.,[25] and López et al.[26] The increased salivary total protein in diabetics could be attributed to the increase in basement membrane permeability, allowing easy and increased passage of serum proteins into the whole saliva via salivary gland and gingival crevices.[23,27,28] Arati et al. and Streckfus et al. have demonstrated highly significant positive correlations in salivary total protein levels among uncontrolled and controlled diabetic groups.[11,19,21]
CONCLUSION
Diabetes mellitus is known to alter the composition of saliva. A few reported studies have shown alteration of salivary constituents in diabetes mellitus. Hence, the purpose of this study was to estimate and compare the levels of salivary potassium, sodium, and total protein in smoker diabetic patients and nondiabetic smokers and controls, and to explore potential of salivary electrolytes [Na+, K+] and total proteins as markers.
The estimated values of salivary constituents add to the data already recorded in Indian population. However, further studies using large samples are required to evaluate the findings in our study.
Footnotes
Source of Support: Nil
Conflict of Interest: None declared.
REFERENCES
- 1.Jessie K, Pang WW, Haji Z, Rahim A, Hashim OH. Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers. Int J Mol Sci. 2010;11:4488–505. doi: 10.3390/ijms11114488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Chan HH, Rahim ZH, Jessie K, Hashim OH, Taiyeb-Ali TB. Salivary proteins associated with periodontitis in patients with type 2 diabetes mellitus. Int J Mol Sci. 2012;13:4642–54. doi: 10.3390/ijms13044642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hayman L, Steffen MJ, Stevens J, Badger E, Tempro P, Fuller B, et al. Smoking and periodontal disease: Discrimination of antibody responses to pathogenic and commensal oral bacteria. Clin Exp Immunol. 2011;164:118–26. doi: 10.1111/j.1365-2249.2010.04314.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Loo J, Yan W, Ramachandran P, Wong D. Comparative human salivary and plasma proteomes. J Dent Res. 2010;89:1016–23. doi: 10.1177/0022034510380414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc. 2006;137:313–21. doi: 10.14219/jada.archive.2006.0180. [DOI] [PubMed] [Google Scholar]
- 6.Sathyapriya S, Bharani G, Nagalingam M. Potential of Salivary Protein as a Biomarker in prognosis of Diabetes mellitus. J Pharm Res. 2011;4:2228–9. [Google Scholar]
- 7.Aydin S, Halifeoglu I, Ozercan IH, Erman F, Kilic N, Aydin S, et al. A Comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects. Peptides. 2005;26:647–52. doi: 10.1016/j.peptides.2004.11.008. [DOI] [PubMed] [Google Scholar]
- 8.Marder MZ, Abelson DC, Mandel ID. Salivary alterations in diabetes mellitus. J Periodontol. 1975;46:567–9. doi: 10.1902/jop.1975.46.9.567. [DOI] [PubMed] [Google Scholar]
- 9.Moore PA, Guggenheimer J, Etzel KR, Weyant RJ, Orchard T. Type 1 diabetesw mellitus, xerostomia and salivay flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:281–91. doi: 10.1067/moe.2001.117815. [DOI] [PubMed] [Google Scholar]
- 10.Chavez EM, Borell LN, Tylor GW, Ship JA. A Longitudinal analysis of salivary flow in control subjects and oral adults with type 2 diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:166–73. doi: 10.1067/moe.2001.112054. [DOI] [PubMed] [Google Scholar]
- 11.Arati SP, Shirish S, Degwekar, Rahul R. Bhowte-“Estimation of salivary glucose, salivary amylase, salivary total protein and salivary flow rate in diabetics in India. J Oral Sci. 2010;52:359–68. doi: 10.2334/josnusd.52.359. [DOI] [PubMed] [Google Scholar]
- 12.Suleyman A. A Comparison of Ghrelin, Glucose, Alpha-amylase and Protein Levels in Saliva from Diabetics. J Biochem Mol Biol. 2007;40:29–35. doi: 10.5483/bmbrep.2007.40.1.029. [DOI] [PubMed] [Google Scholar]
- 13.Samaranayake L. Is saliva the magic diagnostic fluid we are waiting for? Saudi Dent J. 2008;20:67–9. [Google Scholar]
- 14.David TW. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc. 2006;137:313–21. doi: 10.14219/jada.archive.2006.0180. [DOI] [PubMed] [Google Scholar]
- 15.Carda C, Mosquera-Lloreda N, Salom L, de Ferraris Gomez ME, Peydró A. Structural and functional salivary disorders in type 2 diabetic patients. Med Oral Patol Oral Cir Bucal. 2006;11:E309–14. [PubMed] [Google Scholar]
- 16.Sharon A, Hannah BA, Biran I, Yoram K, Szargel R, Gutman D, et al. Salivary composition in diabetic patients. J Oral Med. 1985;40:23–6. [PubMed] [Google Scholar]
- 17.Ben-Aryeh H, Cohen M, Kanter Y, Szargel R, Laufer D. Salivary composition in diabetic patients. J Diabetic Complication. 1988;2:96–9. doi: 10.1016/0891-6632(88)90011-6. [DOI] [PubMed] [Google Scholar]
- 18.Ben-Aryeh H, Serouya R, Kanter Y, Szargel R, Laufer D. Oral health and salivary composition in diabetic patients. J Diabetes Complication. 1993;7:57–62. doi: 10.1016/1056-8727(93)90025-t. [DOI] [PubMed] [Google Scholar]
- 19.Yavuzyilmaz E, Yumak O, Akdoganli T, Yamalik N, Ozer N, Ersov F, et al. The alteration of whole saliva constituents in patients with diabetes mellitus. Aus Dent J. 1996;41:193–7. doi: 10.1111/j.1834-7819.1996.tb04855.x. [DOI] [PubMed] [Google Scholar]
- 20.Marder MZ, Abelson DC, Mandel ID. Saliva alteration in diabetes mellitus. J Periodontol. 1975;46:567–70. doi: 10.1902/jop.1975.46.9.567. [DOI] [PubMed] [Google Scholar]
- 21.Streckfus CF, Welsh S, Marcus S, Brown RS, Cherry-Peppers G, Brown RH. Parotid function and composition of parotid saliva among elderly edentulous African –American diabetics. J Oral Pathol Med. 1994;23:277–9. doi: 10.1111/j.1600-0714.1994.tb00059.x. [DOI] [PubMed] [Google Scholar]
- 22.Khan GJ, Mehmood R, Salah-ud-Din, Ihtesham-ul-Haq Effect of chronic tobacco use on salivary concentrations of sodium and potassium. J Ayab Med Coll Abbottabad. 2003;15:41–4. [PubMed] [Google Scholar]
- 23.Tenovuo J, Lehtonen OP, Viikari J, Larjava H, Vilja P, Tuohimaa P. Immunoglobulins and innate antimicrobial factors in whole saliva of patients with insulin-dependent diabetes mellitus. J Dent Res. 1986;65:62–6. doi: 10.1177/00220345860650011101. [DOI] [PubMed] [Google Scholar]
- 24.Harrison R, Bowen HW. Flow rate and organic constituents of whole saliva in insulin dependent diabetic children and adolescents. Pediatr Dent. 1987;9:287–91. [PubMed] [Google Scholar]
- 25.Pal P, Desai NT, Kannan N, Ahmed Mujib BR, Bastian T. Estimation of salivary glucose, salivary amylase, salivary total protein and periodontal microflora in diabetes mellitus. J Indian Dent Assoc. 2003;74:143–9. [Google Scholar]
- 26.López ME, Colloca ME, Páez RG, Schallmach JN, Koss MA, Chervonagura A. Salivary characteristics of diabetic children. Braz Dent J. 2003;14:26–31. doi: 10.1590/s0103-64402003000100005. [DOI] [PubMed] [Google Scholar]
- 27.Laine MA, Sewón LA, Karjalainen SM, Helenius H, Doroguinskaia A, Lehtonen-Veromaa M. Salivary variables in relation to tobacco smoking and female sex steroid hormone –use in 30 to 59 years old women. Acta Odontol Scand. 2002;60:237–40. doi: 10.1080/000163502760148016. [DOI] [PubMed] [Google Scholar]
- 28.Edgar WM. Saliva: Its secretion, composition and functions. Br Dent J. 1992;172:305–12. doi: 10.1038/sj.bdj.4807861. [DOI] [PubMed] [Google Scholar]
